Dr. Claire Wagner is Head of Corporate Strategy & Market Access at the Bill & Melinda Gates Medical Research Institute where she serves as a member of the executive leadership team and leads the institute's global access strategy across the portfolio as well as related engagement with commercial partners, financial institutions, and multilaterals. Prior to joining the institute, Claire served for several years in Kigali, Rwanda working for Rwanda's Minister of Health co-authoring scientific articles and advancing national health system strengthening programs and pharmaceutical product introductions. She later coordinated a global effort with the Dana-Farber Cancer Institute and the Union for International Cancer Control resulting in the 16-drug 2015 expansion of the World Health Organization's Model List of Essential Medicines for cancer. She has since consulted for pharmaceutical companies and non-profits regarding access to healthcare products and services in low- and middle-income countries. Claire is an Associate Scientist in Medicine in the Division of Global Health Equity at the Brigham and Women's Hospital and is co-author of >40 scientific publications. She has an M.D. from Harvard Medical School and an M.B.A. from Harvard Business School.